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Abstract
Objectives To assess whether international medical graduates passing
the two examinations set by the Professional and Linguistic Assessments
Board (PLAB1 and PLAB2) of the General Medical Council (GMC) are
equivalent to UK graduates at the end of the first foundation year of
medical training (F1), as the GMC requires, and if not, to assess what
changes in the PLAB pass marks might produce equivalence.
Design Data linkage of GMC PLAB performance data with data from
the Royal Colleges of Physicians and the Royal College of General
Practitioners on performance of PLAB graduates and UK graduates at
the MRCP(UK) and MRCGP examinations.
Setting Doctors in training for internal medicine or general practice in
the United Kingdom.
Participants 7829, 5135, and 4387 PLAB graduates on their first attempt
at MRCP(UK) Part 1, Part 2, and PACES assessments from 2001 to
2012 compared with 18 532, 14 094, and 14 376 UK graduates taking
the same assessments; 3160 PLAB1 graduates making their first attempt
at theMRCGPAKT during 2007-12 compared with 14 235 UK graduates;
and 1411 PLAB2 graduates making their first attempt at the MRCGP
CSA during 2010-12 compared with 6935 UK graduates.
Main outcome measures Performance at MRCP(UK) Part 1, Part 2,
and PACES assessments, and MRCGP AKT and CSA assessments in
relation to performance on PLAB1 and PLAB2 assessments, as well as
to International English Language Testing System (IELTS) scores.
MRCP(UK), MRCGP, and PLAB results were analysed as marks relative
to the pass mark at the first attempt.
Results PLAB1 marks were a valid predictor of MRCP(UK) Part 1,
MRCP(UK) Part 2, and MRCGP AKT (r=0.521, 0.390, and 0.490; all
P<0.001). PLAB2marks correlated withMRCP(UK) PACES andMRCGP
CSA (r=0.274, 0.321; both P<0.001). PLAB graduates had significantly
lower MRCP(UK) and MRCGP assessments (Glass’s Δ=0.94, 0.91,
1.40, 1.01, and 1.82 for MRCP(UK) Part 1, Part 2, and PACES and
MRCGP AKT and CSA), and were more likely to fail assessments and
to progress more slowly than UK medical graduates. IELTS scores
correlated significantly with later performance, multiple regression
showing that the effect of PLAB1 (β=0.496) was much stronger than the
effect of IELTS (β=0.086). Changes to PLAB pass marks that would
result in international medical graduate and UK medical graduate
equivalence were assessed in two ways. Method 1 adjusted PLAB pass
marks to equate median performance of PLAB and UK graduates.
Method 2 divided PLAB graduates into 12 equally spaced groups
according to PLAB performance, and compared these with mean
performance of graduates from individual UKmedical schools, assessing
which PLAB groups were equivalent in MRCP(UK) and MRCGP
performance to UK graduates. The twomethods produced similar results.
To produce equivalent performance on the MRCP and MRGP
examinations, the pass mark for PLAB1 would require raising by about
27 marks (13%) and for PLAB2 by about 15-16 marks (20%) above the
present standard.
Conclusions PLAB is a valid assessment of medical knowledge and
clinical skills, correlating well with performance at MRCP(UK) and
MRCGP. PLAB graduates’ knowledge and skills at MRCP(UK) and
MRCGP are over one standard deviation below those of UK graduates,
although differences in training quality cannot be taken into account.
Equivalent performance in MRCGP(UK) and MRCGP would occur if the
pass marks of PLAB1 and PLAB2 were raised considerably, but that
would also reduce the pass rate, with implications for medical workforce
planning. Increasing IELTS requirements would have less impact on
equivalence than raising PLAB pass marks.
Introduction
International medical graduates who wish to practise medicine
in the UK can be accepted onto the List of Registered Medical
Practitioners of the General Medical Council (GMC) by passing
the two examinations set by the GMC’s Professional and
Linguistic Assessments Board (PLAB). International medical
graduates usually possess qualifications from outside the
European Economic Area (EEA), as doctors with an EEA
medical qualification who have EU rights can normally be
registered under reciprocal arrangements. Figure 1⇓ provides a
synopsis of the training and assessment undertaken in the UK
by international medical graduates and by UK medical
graduates.
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PLAB Part 1 is a multiple choice assessment of medical
knowledge in four domains (context, diagnosis, investigation,
management), and PLABPart 2, which is an objective structured
clinical examination, also assesses in four domains
(communication, history taking, examination, practical skills).
A current pre-condition for taking PLAB is that international
medical graduates have within the previous two years achieved
an acceptable level at IELTS (International English Language
Testing System1) with a score of at least 7 in each of its four
domains (listening, reading, writing, speaking). In the five years
from 2008-12 an average of 1281 international medical
graduates per year passed PLAB, and in the same period an
annual average of 6720 UK graduates fully registered with the
General Medical Council (GMC, personal communication).
PLAB graduates are similar in number to the output of four or
five medium sized UK medical schools.
The desired standard for the PLAB exams has been consistently
stated since the introduction of the assessment in 1975, when
it was known as the TRAB (Temporary Registration Assessment
Board) assessment.2-4 In the 2003 review of PLAB the standard
was justified and summarised thus: “Council has agreed that…
[it] would be inequitable to expect UK-trained doctors and
international medical graduates to satisfy different standards to
obtain full registration. For these reasons we have concluded
that the standard of the test should be that of doctors completing
the end of Foundation Year 1”(Para 15).4
In 2011 the GMC set up a working party to review the PLAB
examinations once again. Included within the remit was an
assessment of whether “the knowledge and skills demonstrated
by a pass in the PLAB test continue to be equivalent to those
demonstrated by successful completion of [Foundation Year 1]
training.”
In addition the working party was asked “to examine whether
international medical graduates granted full registration
following a successful pass in the PLAB test are more or less
likely than other cohorts of doctors to experience difficulties in
medical practice in the UK” by “examining any evidence of
disparity between the success rates of UK medical graduates
and international medical graduates in postgraduate
examinations and assessments.”5
As a part of addressing these questions the Working Party
commissioned two sets of primary research, and the present
study is one.
International medical graduates and the
MRCGP
Although the PLAB Working Party had been considering the
performance of international medical graduates before then, the
performance of international medical graduates in postgraduate
medical examinations came under intense scrutiny in 2013 in
relation to pass rates of international medical graduates in the
MRCGP. The examination is in two parts, the AKT (Applied
Knowledge Test, a multiple choice examination) and the CSA
(Clinical Skills Assessment, a 13-station simulated surgery in
objective structured clinical examination format). In February
2013, leave for a judicial review into differential pass rates of
international medical graduates at the CSA was sought by the
British Association of Physicians of Indian Origin and agreed
to by the administrative court in July 2013 (and took place in
April 2014). In April 2013 the GMC also set up an independent
enquiry into the MRCGP, the ensuing “Esmail and Roberts
report” being published in September 2013,6 along with a
parallel article in the BMJ.7 That report examined the
performance of 5095 doctors who had taken MRCGP exams
and for whom ethnicity was known (2663 being white and 2432
being “black and minority ethnic”). Of these doctors, 1310
candidates were international medical graduates, 3644 were UK
graduates, and 141 were EEA graduates, with most international
medical graduates being classified as black and minority ethnic.
Esmail and Roberts reported that international medical graduates
were 14.7 times more likely to fail the CSA than UK graduates
after “correcting for age, gender and performance at AKT,” and
2.9 times more likely to fail the AKT.7 In addition, among UK
graduates, black and minority ethnic candidates were 3.5 times
more likely to fail the CSA than white graduates. The report to
the GMC concluded that differences on the machine-marked
AKTwere “difficult to attribute to… bias” and that “the reasons
for the differential pass rates are likely to be complex” (p 14),6
and were consistent with differences reported more generally
in medical examinations8 at both the postgraduate and
undergraduate level (for whichmany possible explanations have
been tested9 10).
Esmail and Roberts posited a number of possible reasons for
the lower performance of international medical graduates in the
CSA, including differences in preparedness for an assessment,
“which is not a culturally neutral examination and nor it is
intended to be” (p 15).6 The format of the CSA examination
itself was not felt to be a problem, being “based on a
well-established pedagogy.” However, it was noted that “the
nature of the examination is such that it is open to subjective
bias” on the part perhaps of examiners or of simulated patients,
although no statistical evidence was presented. A
recommendation of the Esmail and Roberts report was that
“further research should be commissioned… to investigate how
black and minority ethnic standardised patients and black and
minority ethnic examiners score candidate physicians who are
racially and ethnically concordant and compare that to how
non-concordant standardised patients and examiners score the
black and minority ethnic candidates” (p 19). Group analyses
of examiner and candidate concordance for ethnicity inMRCGP
by one of us find little evidence of bias,11 and are consistent
with similar analyses of MRCP(UK) at the group level12 and
the individual examiner level.13 Despite Esmail and Roberts’
claim that “subjective bias owing to racial discrimination cannot
be excluded,”7 it seems unlikely from our empirical analyses11-13
that racial discrimination is an explanation for differential
performance by international medical graduates in exams such
as MRCGP and MRCP(UK).
The lower performance of international medical graduates in
the MRCGP examination is not unique to that exam, although
data from other postgraduate examinations are less easy to
interpret as some or many international medical graduates are
not UK trainees or are not even registered in the UK. Bearing
that in mind, theMRCP(UK) has published data for some years
from which it is clear that international medical graduates
perform less well.14 Lower international medical graduate
performance has also been reported in the MRCPsych
examination,15 and it is also clear that international medical
graduates perform less well in the MRCOG examination16 17
and in the assessments towards MRCPCH.18
Equivalence
A central, but difficult, concept which is present within the remit
of the GMC working party is the concept of equivalence—the
term being used explicitly in one remit (“continue to be
equivalent”), which we will call “entry equivalence,” and
implicitly in the other (“more or less likely … to experience
difficulties”), which we will call “outcome equivalence,”
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equivalence being neither more nor less likely to experience
difficulties. Problems in defining equivalence also occur with
the Certificate of Eligibility for Specialist Registration and
Certificate of Eligibility for GP Registration, which are
alternative routes for international medical graduates (and some
UK graduates) to enter the specialist or GP registers.19
Within medicine the concept of equivalence testing has been
used since the 1980s in clinical pharmacology to assess whether
two compounds are sufficiently similar to be considered
equivalent20 (and the methodology is also used elsewhere21).
Equivalence testing typically considers a single parameter, such
as the mean or the peak level of a drug. Although a mean can
describe a distribution, it is not the only important parameter.
The abilities of UK and PLAB graduates form distributions,
with some graduates being excellent and others being barely
acceptable. The phrase “equivalent to ... doctors who have
successfully completed F1” for defining entry equivalence is
unclear. Although it could mean that means or medians should
be equivalent, it might also be interpreted, since PLAB is a
qualifying examination, that all PLAB graduates should be at
least as good as, say, the worst UK graduate on the register.
The main concern of the present study is in assessing outcome
equivalence in relation to MRCP(UK) and MRCGP, and we
will compare the median performance of PLAB and UK
graduates, and we will also compare PLAB graduates who pass
the exam at different levels with the average performance of
graduates from different UK medical schools.
Direct and indirect comparison
Evaluating the equivalence of different assessments is never
straightforward unless either there are two groups of individuals
taking the same assessment22 or there is cross moderation of
judgemental methods23 allowing a direct comparison. UK
graduates who have “successfully completed the first year of
Foundation Programme training” do not take PLAB (or indeed
any other summative assessment at the end of the first
foundation year), and PLAB graduates will not have taken UK
medical school finals. Neither are there shared questions in
PLAB and UK medical school finals (indeed, because UK
medical schools run their own final examinations, different
items are used in different schools, and standards may differ
between UK medical schools24). Direct assessment of the entry
equivalence of PLAB is not therefore possible at present. An
indirect assessment of entry equivalence could compare groups
such as PLAB and UK graduates on some other assessment
taken by both groups—an external yardstick. For the present
study the yardstick is performance in the MRCGP and
MRCP(UK) examinations, and the yardstick of the Annual
Review of Competence Progression is analysed in a separate
report by a different team.25
The logic of the current study is straightforward: MRCP(UK)
andMRCGP exams are taken by bothUK and PLAB graduates,
and if the UK and PLAB graduates are equivalent in their
outcomes then they should perform equally well when they take
the MRCP(UK) and MRCGP. The situation is made somewhat
more complex as UK and PLAB graduates choose which
medical specialty to enter, and they are also selected onto
training programmes such as for general practice or for core
medical training. Those taking the examinations may not
therefore be representative samples, although they are at least
complete samples of UK and PLAB graduates taking
MRCP(UK) and MRCGP in the years concerned.
Validity
Our analyses can be considered as an exercise in assessing the
validity of the PLAB assessments. High stakes examinations
have a pass mark (“cut score” or “passing score”), and, although
little discussed in the literature, a key question concerns the
validity of that pass mark. Kane26 distinguishes clearly between
a pass mark and a performance standard, the latter being a
measure of adequate performance in the domain to which
passing the assessment allows access. For Kane, “Validation
… consists of a demonstration that the proposed passing score
can be interpreted as representing an appropriate performance
standard.”
Kane distinguishes several types of validity. “Procedural
validity” is the appropriateness of the procedures used in
standard setting, with poor procedure casting doubt on the
validity of a pass mark but good procedure alone being unable
to validate a pass mark. “Internal validity” of standard setting
assesses examiner agreement on the pass mark, and it alone also
cannot validate a pass mark—as Verheggen et al wrote,
judgments can be “more reliable, [but] they may [also] be less
valid. In other words the judgements would be consistently off
the mark” (p 210).27 Kane’s third approach to validity uses
external criteria, particularly the “direct, criterion-related
approach,” asking how those passing the exam perform at later
tasks, whether those who pass well perform better than those
who only just pass and whether those only just passing
subsequently perform at an acceptable level. That is the approach
adopted in this paper, although we refer to it as indirect.
The present study
The study reported here uses record linkage, based on GMC
registration number, to assess performance in a large group of
PLAB graduates who have gone on to take the MRCP(UK)
and/or MRCGP examinations. The analyses presented here
differ from those reported by Esmail and Roberts in some
important ways. Firstly, the analyses have a large dataset from
MRCP(UK), and, secondly, extensive analysis is carried out of
PLAB Part 1 examination results (which Esmail and Roberts
chose not to study (p 11)6). The primary interest is in the extent
to which PLAB and UK graduates are equivalent in their
subsequent postgraduate performance, with a secondary interest
in whether a change in the standard set for the PLAB
assessments could result in outcome equivalence. As will be
discussed later, it is accepted that other factors might also be of
importance in determining differences in international medical
graduate and UK medical graduate performance.
Method
The study used data linkage for the main analyses, with data
protection and other issues constraining how the linkage took
place. Data linkage in the first instance took place at the GMC,
to which was sent by the MRCP(UK) and MRCGP office the
GMC number, name, date of birth, and place of primarymedical
qualification of all candidates known to have takenMRCP(UK)
or MRCGP. The GMC did not receive either MRCP(UK) or
MRCGP examination results themselves. Having identified
doctors in those sets who had also taken PLAB, the GMC then
sent data files with information on PLAB and IELTS
performance to ICM and RW, who separately linked the PLAB
and IELTS data with MRCP(UK) performance and MRCGP
performance. The fully linked datasets were available to ICM
and RW only, on a research basis, each processing data only
from their own college, and were not available either to the
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GMC or to the Royal Colleges of Physicians or the Royal
College of General Practitioners.
Descriptions of the various sets of data
MRCP(UK)—Run by MRCP(UK) Central Office for the
Federation of Royal Colleges of Physicians of London,
Edinburgh and Glasgow, the exam is in three parts. MRCP Part
1 is a 200-item, “best of five” multiple choice assessment with
brief clinical vignettes, which is computer marked. MRCP Part
2 is a 270-item, computer marked, “best of five” assessment
with more complex and extensive clinical scenarios. PACES
(Practical Assessment of Clinical and Examination Skills) is a
modified objective structured clinical examination, with eight
encounters, six involving real patients and two involving
simulated patients, with two examiners present at each station.
The original PACES examination28 changed its format in 2009
to new PACES (nPACES).29 The MRCP(UK) Part 1 and Part
2 examinations have had essentially the same structure since
2001-02,30 although the method of standard setting for both was
changed from the Angoff method to statistical equating in 2009
and 2010 respectively. Part 1 can be taken 12 months after
graduation. Part 2 and PACES can be taken in any order once
Part 1 has been passed.
MRCGP—These examinations, which are run by the Royal
College of General Practitioners, are in two parts, the AKT
(Applied Knowledge Test, a 200-item, computer displayed and
computer marked, multiple choice test with a variety of item
types) and the CSA (Clinical Skills Assessment, a 13-station
objective structured clinical assessment in the form of a
simulated surgery with candidates seeing simulated patients
while being assessed by an examiner). The AKT is typically
taken during the second year of training, and the CSA is taken
during the third and normally final year of training. All
candidates are onUK training schemes overseen by postgraduate
deaneries; entry to the examinations by others (such as foreign
based candidates) is not allowed.
PLAB—PLAB Part 1 (knowledge assessment) is currently a
multiple choice, best of five examination with 200 items, of
which a small number are removed because of problems in
keying or scoring, a typical exam having 197 scored items. The
pass mark is set by a variant of the Angoff method and is
typically about 125, but has varied in the range 116 to 135.
Marks on the four subscales are not reported here. PLAB Part
2 (the clinical assessment) is an objective structured clinical
assessment, candidates being assessed on 15 stations, one of
which is a non-scoring pilot station. There are four types of
station, but subscores will not be considered here. There is a
single examiner at each station, and the standardised patients
do not take part in marking the assessments. The marking
scheme is complex, but has been described elsewhere (www.
gmc-uk.org/doctors/plab/borderline_group_scoring_faqs.asp),
along with the standard setting method, which is a variant of
the borderline group method.
IELTS—The required IELTS level for PLAB has varied over
the years but is currently set at a score of 7 on the total score
and at all four subscores. Candidates taking PLAB in earlier
years may have had lower scores either overall or on subscales.
Some PLAB candidates are exempted from the required IELTS
level, primarily by demonstrating that their training was at a
medical school where the great majority of teaching is in
English. Analyses of IELTS are restricted here to the overall
score attained.
Mark relative to the pass mark
Pass marks vary from diet to diet of the various examinations,
and therefore performance atMRCP(UK),MRCGP, and PLAB
is described in terms of mark relative to the pass mark, so that
a candidate scoring zero just passes the exam, a candidate with
a positive mark has passed the examination with marks to spare,
and candidates with a negativemark have failed the examination.
We have also carried out analyses based on marks attained at
passing, but they aremore complex, in particular having skewed,
censored distributions, and are less statistically sensitive but
give broadly similar results.
Repeated attempts at examinations
Candidates who fail assessments can repeat MRCP(UK),
MRCGP, and PLAB. Here we use candidates’ marks at first
attempt for all analyses, as did Esmail and Roberts. Previous
analyses of MRCP(UK) have suggested that mark at the first
attempt of taking an examination is the best predictor of future
performance31 and thus the most accurate measure of ability.
Statistical methods
Statistical analyses used IBM Statistical Package for the Social
Sciences v21. Effect sizes are calculated as Glass’s delta (Δ),
which expresses the performance of PLAB graduates relative
to the UK graduates who are regarded as the reference group.
Results
Linkage of the MRCP(UK) and PLAB
databases
The database for the current analysis consisted initially of all
65 115 candidates who had taken at least one part of the
MRCP(UK) examination between 2001 and 2012. Of these, 37
329 had a GMC number and therefore had at some point worked
in the UK. Linkage with the PLAB database identified 9818
PLAB candidates who were also MRCP(UK) candidates. Of
the remaining MRCP(UK) candidates, 24 641 had graduated at
UK medical schools and are the group to be compared with the
PLAB candidates and with whom they should be equivalent.
Results at first attempt were not available for all candidates as
exams may have been taken outside of the available time
window. Marks at first attempt were available for 18 532 UK
graduates at Part 1, 14 094 UK graduates at Part 2, and 14 376
UK graduates at PACES, and for 7829 PLAB graduates at Part
1, 5135 PLAB graduates at Part 2, and 4387 PLAB graduates
at PACES.
Linkage of the MRCGP and PLAB databases
Two databases were created for theMRCGP and PLAB linkage,
one for the AKT and the other for the CSA. Linkage with the
PLAB database was carried out by the GMC looking for all
PLAB candidates who had a GMC number in the lists of those
taking either or both parts of the MRCGP. There were data
available on the AKT between 2008 and 2013 for a total of 22
081 candidate attempts, of which 17 395 were first attempts.
Of these first attempts, 3160 were for PLAB Part 1 and 3067
for PLAB Part 2, and 2985 had IELTS scores reported. For the
current version of the CSA (2010-13), from a total of 11 673
candidate attempts, 8346 were first attempts. Of these, 1411
were for PLAB Part 1, and 1388 for PLAB Part 2, and 1353
had IELTS scores reported.
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Representativeness of PLABgraduates taking
MRCP(UK) and MRCGP
PLAB graduates taking MRCP(UK) or MRCGP may be
different from those who do not take those examinations. Table
1⇓ shows performance at PLAB Part 1 and PLAB Part 2 in all
doctors who passed PLAB 1 between 4 July 2000 and 13 July
2006 and passed PLAB 2 between 13 June 2001 and 12 January
2007 in relation to whether they had ever taken the MRCGP or
MRCP(UK) exams.
PLAB graduates who took MRCP(UK) performed somewhat
better on their first attempt at PLAB Part 1, although the effect
is small, and they performed a little worse at their first attempt
at PLAB Part 2. PLAB graduates who took the MRCGP exams
scored somewhat lower on their first attempt at PLAB Part 1
and a little better at their first attempt at PLAB Part 2.
Comparison of UK and PLAB graduates on
demographics and progression
Table 2⇓ shows basic descriptive data on demographics and
progression for PLAB and UK graduates taking MRCP(UK)
and the MRCGP.
For theMRCP(UK), PLAB graduates are more likely to bemale
and to be from ethnic minorities. UK and PLAB graduates
qualify as doctors at similar ages, but PLAB graduates take
MRCP(UK) later than UK graduates, not least because they
have been taking PLAB Parts 1 and 2 between graduation and
taking MRCP(UK) Part 1. PLAB graduates also progress more
slowly through MRCP(UK) Parts 1, 2, and PACES (in large
part due to having more resits, data not shown).
For the MRCGP, PLAB graduates are more likely than UK
graduates to be male and far more likely to be non-white. PLAB
graduates are four years older when they take the AKT and six
years older when they take the CSA. PLAB graduates are far
more likely to resit both the AKT and CSA than UK graduates
(mean attempt number in AKT database=1.16 for UK graduates,
1.64 for PLAB graduates, P<0.001; mean attempt number in
CSA database=1.12 for UK graduates, 2.17 for PLAB graduates,
P<0.001).
Data on nationality are available only for the candidates taking
PLAB, but, as table 2⇓ shows, there is a large group of PLAB
candidates who are UK nationals, about 8% (749/9589) for those
taking MRCP(UK), and 12% (388/3233) for the MRCGP. The
MRCGP candidates who were UK nationals took significantly
more attempts to pass PLAB Part 1 than those who were of
other nationalities (mean: 1.8 attempts v 1.4 attempts, P<0.001),
first attempt score on PLAB Part 1 was also significantly lower
than for non-UK nationals (mean 2.98 v 7.21, P<0.001), and
they also performed less well on the AKT (mean −2.54 v 4.67,
P<0.001), whereas on the CSA they were not statistically
different from non-UK nationals (mean −3.45 v −4.81, not
significant).
Correlation of PLAB results with MRCP(UK)
and MRCGP results
If PLAB is a valid assessment of skills relevant to progression
during UK postgraduate training then performance on it should
relate to performance on subsequent UK postgraduate
assessments. Elsewhere, in longitudinal studies of UK graduates,
it has been shown that there are strong continuities across
performance in secondary school assessments, undergraduate
medical school performance, and postgraduate examination
performance in the form of MRCP(UK),32 with a preliminary
analysis suggesting that MRCGP also correlates in a similar
way. This we have called the “academic backbone,” and it
suggests that medical training is part of a continual acquisition
of what we have called “medical capital.”
Better performance on the two parts of PLAB correlates with
better performance on the various parts of MRCP(UK) and of
MRCGP (table 3⇓). There is also specificity in that the
knowledge based assessment of PLAB Part 1 particularly
correlates with MRCP(UK) Part 1 and MRCGP AKT, whereas
the clinical assessment of PLAB Part 2 correlates better with
MRCP(UK) PACES and MRCGP CSA, both of which are
clinical assessments. PLAB therefore has predictive validity for
MRCP(UK) and MRCGP.
For comparative purposes, table 3⇓ also shows correlations
between the separate parts ofMRCP(UK) andMRCGP for those
candidates who happen to have taken both assessments.33Again
there is specificity, with knowledge based assessments
correlating highly (r=0.673 betweenMRCP(UK) Part 1 and the
AKT), and the clinical examinations (PACES and the CSA)
also correlating highly (r=0.496). The latter correlation is
particularly important, as it suggests that the modest correlation
between PLAB Part 2 and both PACES (r=0.186) and the CSA
(r=0.321) is not a reflection of poor correlation between clinical
assessments in general but is more likely explained by the
relatively low reliability of PLAB Part 2, which unpublished
analyses suggest is in the range 0.55 to 0.71.
Outcome equivalence of MRCP(UK) and
MRCGP candidates who are international
medical graduates or UK medical graduates
If UK and PLAB graduates are outcome equivalent then the
simplest of predictions is that their mean scores on the
MRCP(UK) orMRCGP assessments should be the same. Table
4⇓ shows that they are not. For all of the assessments, the mean
marks of PLAB graduates are substantially below those of UK
graduates. The size of the effect is calculated as Glass’s Δ (the
difference in the mean scores divided by the standard deviation
of the reference group, which here is the UK graduates). Glass’s
Δ is −0.94, −0.91, and −1.40 forMRCP(UK) Part 1, Part 2, and
PACES, and −1.01 and −1.82 for MRCGP AKT and CSA. A
conventional classification describes effect sizes of greater than
0.8 as “large,” and these values are undoubtedly substantial, the
average Glass’s Δ of −1.22 meaning there is about one and a
quarter standard deviations between the UK and the PLAB
groups.
The finding of a clear difference in performance of UK and
PLAB candidates, coupled with a good correlation between
PLAB scores and subsequent performances in MRCP(UK) and
MRCGP, raises the immediate question of what a pass mark
for PLAB might need to be, all other things being equal, to
achieve outcome equivalence betweenUK and PLAB graduates.
We therefore describe two separate methods of estimating a
pass mark that would result in equivalent subsequent
performance of UK and PLAB graduates on the MRCP(UK)
and MRCGP examinations.
Method 1: Equating to median performance of
UK graduates
A typical UK graduate takingMRCP(UK) Part 1 is at themedian
level of performance on that assessment, so that half of UK
graduates perform better and half perform less well. Figure 2⇓
shows how the equivalent median for PLAB graduates may be
estimated.
• The distribution of marks of UK graduates taking
MRCP(UK) Part 1 is shown at the far right in blue.
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• On a scale relative to the pass mark of zero, their median
mark is +1.03, shown as the thick horizontal red line, so
that UK graduates are therefore slightly more likely to pass
than to fail MRCP(UK) Part 1 on their first attempt.
• The marks of the PLAB graduates at MRCP(UK) Part 1
are shown in the pale yellow histogram, third from the
right.
• This distribution is clearly shifted downwards relative to
the UK graduates, and the mark of +1.03, which is at the
median for UK graduates, is on the 81st centile of the
PLAB graduates.
• The horizontal orange histogram at the bottom shows the
distribution of marks at first attempt on PLAB Part 1 by
PLAB graduates.
• Finding a pass mark that results in equivalence with the
UK distribution requires a pass mark to be set at PLAB
Part 1, which results in a distribution of MRCP(UK) Part
1 scores in PLAB graduates which has a median of +1.03,
the same as that for UK graduates.
• That can be estimated by considering only PLAB graduates
with a mark higher than some threshold, which can be
adjusted until the median of those taking MRCP(UK) Part
1 is +1.03.
• The dark green vertical line in fig 2 is set at such a
threshold (“pass mark”) of +25.
• TheMRCP(UK) Part 1 marks of all those PLAB graduates
to the right of the dark green line are shown in the middle,
pale green histogram at top right, and for this group the
median is very close to +1.03, half being above that value
and half below it.
On that basis, a pass mark for PLAB Part 1 of +25 compared
with the present pass mark (which is defined as zero) would
result in a group of PLAB graduates performing equivalently
on MRCP(UK) Part 1 to UK graduates. Of the 7823 PLAB
graduates taking MRCP(UK) Part 1, only 1409 (18.0%) are in
the green distribution.
A similar analysis can be carried out for MRCP(UK) Part 2 in
relation to PLAB Part 1. For UK graduates the median is +6.01,
a value which is at the 82nd centile for PLAB graduates.
Adjusting the threshold for PLAB Part 1 until the PLAB
graduates have a median of +6.01 requires a threshold of +32
compared with the present PLAB Part 1 pass mark of zero; on
that basis, 516 of the 5133 PLAB graduates currently taking
MRCP(UK) Part 2 are equivalent to UK graduates (10.1%).
MRCP(UK) PACES is more problematic for calculating an
equivalent threshold. The UK graduates have a median mark
of +2.0 on PACES, a mark that is at the 91st centile for PLAB
graduates. However it is not possible to get a threshold for PLAB
Part 2 which produces a median of +2.0, there simply being no
candidates left. The best that can be said therefore is that the
threshold is >+18.
The analyses for MRCGP are similar. The median AKT mark
for MRCGP UK graduates is 21 and for PLAB graduates is 5,
and the median CSAmark for MRCGP UK graduates is 14 and
that for PLAB graduates is −5. To achieve an equivalently
performing median candidate as between UK graduates and
PLAB candidates on first attempt would require the pass mark
for PLAB Part 1 to be increased by +35 marks and that for
PLAB Part 2 to be increased by +10 marks. Using these values
as a pass mark would result in many fewer PLAB graduates
taking MRCGP, 106 of the 3160 taking AKT (3.4%) and 114
of the 1388 taking CSA (8.2%).
Method 2: Comparison with performance of
graduates from different UK medical schools
The second method takes a rather different approach. In a
previous analysis of the performance of graduates of different
UKmedical schools at MRCP(UK)24 there were clear and large
differences in performance at MRCP(UK) between graduates
of different medical schools. That result extended and developed
the much earlier analysis of Wakeford et al34 for MRCGP, and
has been repeated in recent analyses of the MRCGP.35 Similar
differences between medical schools have also been reported
for FRCA36 andMRCOG.16The ordering across medical schools
is broadly similar in all of the studies, with some variation due
to sampling differences, and perhaps also differences in medical
school training.
Our second method addressed the question of equivalence by
estimating the level of performance at PLAB which results in
a similar performance to that of graduates from the various UK
medical schools. The PLAB graduates have therefore been
divided into 12 equally spaced subgroups according to
performance at PLAB Part 1 (or Part 2), which groups can then
be compared with graduates of individual UK medical schools.
Subgroups were based on steps of five marks for PLAB Part 1
and steps of three marks for PLAB Part 2, so that groups can
be directly compared with the marking scales for each
assessment.
Figure 3⇓ shows results for MRCP(UK) Part 1. The blue points
show performance of graduates of UKmedical schools, ranked
from highest to lowest. New medical schools, whose graduates
have not been taking MRCP(UK) for long enough to establish
stable patterns in their results, have been omitted as numbers
are not yet large enough to have reasonable standard errors.
Differences between UKmedical schools are highly significant,
as can be seen from the narrowness of the 95% confidence
intervals, but they are not of direct interest here. PLAB graduates
are shown as the 12 red points, corresponding to the different
grouping of marks at the first attempt at PLAB Part 1, relative
to the pass mark. A separate group of EEA graduates who are
not required to take PLAB is shown as a green point. PLAB
groups were regarded as equivalent to UK medical schools if,
using the Ryan-Einot-Gabriel-Welsch Q post hoc test, their
performance was not significantly different from a UKmedical
school.
The highest scoring PLAB group (“PLAB1 A1 35+” which
scored ≥35 marks above the PLAB1 pass mark) has a mean
performance equivalent or better than the mean performance of
graduates of all but two of the UKmedical schools (Oxford and
Cambridge) and is clearly achieving very highly. Similarly the
second and third groups (“PLAB1 A1 30-34” and “PLAB1 A1
25-29” have a mean performance better than or similar to the
graduates of many UK medical schools. The fourth group
(“PLAB1 A1 20-24”) with PLAB scores 20-24 points above
the pass mark, has a mean performance that is not
distinguishable from the mean performance of the lowest
performing UK medical school, using the
Ryan-Einot-Gabriel-WelschQ post hoc test. The eight remaining
PLAB1 groups, from “PLAB1 A1 15-19” downwards, all
perform at a significantly lower average level than graduates of
any of the UK medical schools. Taken overall, figure 3⇓
suggests that the top four PLAB1 groups are equivalent to
graduates from UK medical schools when taking MRCP(UK)
Part 1, whereas the lower eight groups perform less well. Those
results suggest that an equivalence level is +20 to +24 points
above the current pass mark. In this figure (and figs 4-7) an
orange dotted line marks the mean scores of the lowest
performing UK university or medical school.
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Similar calculations can be carried out for MRCP(UK) Part 2
in relation to PLAB Part 1, and for MRCP(UK) PACES in
relation to PLAB Part 2, and plots are shown in figures 4⇓ and
5⇓. For MRCP(UK) Part 2 (fig 4), the mean performance of
only the top two PLAB groups (30-34 and 35+) is equivalent
to that of UK graduates, making +30 to +34 the likely
equivalence. For PACES (fig 5⇓), only the top two groups are
equivalent to graduates of UK medical schools, making the
equivalence +16 to +18.
Analyses for the MRCGP are shown in figures 6⇓ and 7⇓,
comparing performance in the AKT in relation to PLAB Part 1
and in the CSA in relation to PLAB Part 2. Note that the
MRCGP database subdivides London medical schools.
For the AKT (fig 6⇓), the top PLAB group, with PLAB Part 1
scores of ≥35 above the pass mark, is clearly equivalent to many
UK medical schools, as are all of the top five groups including
PLAB Part 1 mark 15-19. However the group with PLAB Part
1 mark 10-14 is performing significantly less well. A probable
equivalence is therefore at +15 to +19.
For the CSA (fig 7⇓), only the PLAB Part 2 16-18 group and
the (very small) PLAB Part 2 18+ group are equivalent to the
lowest scoring UK medical school, suggesting that PLAB Part
2 scores of +16 to +18 would be necessary for equivalence.
Summary: overall estimate of PLAB1 and
PLAB2 pass marks for outcome equivalence
A simple comparison of themean performance of UK and PLAB
graduates on MRCP(UK) and MRCGP makes clear that there
is not outcome equivalence, PLAB graduates perform less well
by about one and a quarter standard deviations. Two methods
are described for estimating how PLAB pass marks could be
altered to result in outcome equivalence, both making the
assumption that all other factors are similar between the two
groups. The method of equating medians, and comparing
performance with graduates of individual UK medical schools,
give slightly different results, which are summarised in table
5⇓.
Estimating an equivalence level of PLAB Part 1 for the
knowledge assessments of MRCP(UK) Parts 1 and 2 and
MRCGP AKT using the two methods suggests overall that a
pass mark of the order of +27marks higher than at present would
result in outcome equivalence (+31 based on method 1 and +24
based on method 2). Since the PLAB Part 1 typically has nearly
200 questions, in terms of percentage of items correct, the pass
mark would need to be moved from its present level of about
63% to about 76%.
For PLAB Part 2, both methods find that a considerably higher
PLAB pass mark would be needed to achieve outcome
equivalence, there being barely any level of attainment at PLAB
Part 2 which is equivalent to the performance of UK graduates,
so that only the very top performers seem to be equivalent to
UK graduates. Averaging across the estimates, the pass mark
would seem to need to rise by about +15 to +16 marks (+14
based on method 1 and +17 based on method 2). Some of the
problems with estimating may result either from the assessment
not stretching candidates at the top end, or from the relatively
low reliability of Part 2, an aspect of the assessment which
inevitably makes its predictive power less than is desirable.
It should be reiterated that these calculations make the
assumption that the only differences between the groups are in
the pass mark for PLAB (see discussion).
The role of IELTS on performance in PLAB
and in MRCP(UK) and MRCGP
PLAB candidates have mostly attained the required level at
IELTS, although some are exempted. Since PLAB is an
assessment carried out in English, as are MRCP(UK) and
MRCGP, an important question concerns the extent to which
poor performance at later postgraduate qualifications may be
mediated via problems with English. We have investigated that
for both MRCP(UK) and MRCGP, but only report here the
results for MRCGP. Few PLAB candidates had IELTS scores
below 7 or over 8, and we therefore divided the candidates into
three groups: ≤7, 7.5, and ≥8.
Figure 8⇓ shows performance at the MRCGP AKT in relation
to performance at PLAB Part 1 at the first attempt and the IELTS
level, the “traffic lights” showing that, at most levels of PLAB
1 performance, those with the highest IELTS scores (green)
perform better than those with the lowest IELTS scores (red).
IELTS is clearly therefore important. However a multiple
regression shows that the predictive effect of PLAB Part 1
(β=0.496) is very much stronger than the effect of IELTS
(β=0.086).
Figure 9⇓ shows a similar analysis for performance at the
MRCGP CSA, broken down by PLAB Part 2 performance at
first attempt and IELTS level, shown as traffic lights. The effects
are somewhat less clear, in some cases due to smaller sample
sizes. Again, the multiple regression shows the effect of PLAB
Part 2 (β=0.278) is stronger than that for IELTS (β=0.187). The
lower effect of PLAB Part 2 (compared with PLAB Part 1 on
the AKT) probably reflects the lower reliability of PLAB Part
2, and the larger effect of IELTS is probably due to the greater
importance of language, particularly spoken language, in a
clinical examination.
Discussion
The results of this data linkage study show that there are good
correlations between PLAB and the subsequent assessments of
MRCP(UK) and MRCGP, which means that PLAB is a valid
assessment of skills relevant to progression during UK
postgraduate training (that is, there is construct equivalence).
It is also clear that, compared with UK graduates, PLAB
graduates perform less well in two major postgraduate medical
examinations in the UK, so that there is not criterion related
outcome equivalence. Outcome equivalence could be produced
were the pass mark for PLAB to be set at a higher level than it
currently is, although that and the other conclusions have
important caveats and need to be interpreted with care.
Construct equivalence
Performance in PLAB Part 1 correlates well with subsequent
performance on MRCP(UK) and MRCGP, suggesting that the
constructs it is measuring are parallel to those assessed by the
two postgraduate examinations, and MRCP(UK) and MRCGP
also correlate strongly in candidates who take both assessments.33
Additionally, as table 3⇓ shows, knowledge tests shows stronger
correlations with other knowledge tests, and clinical tests with
other clinical tests, suggesting that knowledge and clinical tests
assess separate but related domains. The three assessments are
therefore measuring similar underlying constructs of knowledge
and clinical skills. PLAB is reliably putting candidates into a
meaningful order that predicts other postgraduate outcomes in
a way which is probably similar to UK medical school finals.32
PLAB therefore seems to act in a similar way to the “academic
backbone” which underpins secondary school, undergraduate,
and postgraduate performance in UK medical students and
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graduates,32 and which involves the continual development of
the skills, knowledge, and expertise that underpin competent
medical practice—the acquisition of “medical capital.”
Criterion related outcome equivalence
That PLAB graduates do not progress through their careers in
the same way as UK graduates seems clear from table 4⇓. That
the difference is not merely in the summative assessments for
these two specialties is shown by the parallel analysis of PLAB
in relation to the Annual Review of Competence Progression,25
which suggests that the lack of progression is in workplace
based assessments and deanery assessments of progress across
the entire range of medical specialties. PLAB graduates do not
therefore show criterion related outcome equivalence.
Explaining the lack of outcome equivalence is more complex,
and several factors are considered below.
The extent of non-equivalence
The extent of non-equivalence can be evaluated numerically by
considering at what level the PLAB pass mark would need to
be set in order to produce outcome equivalence. We have
described two methods. One of our methods considers the
performance of a median UK graduate at MRCP(UK) and
MRCGP and asks what PLAB pass mark would result in a
median PLAB graduate performing at the same level in
MRCP(UK) andMRCGP as that median UK graduate (see table
5⇓).
A potential problem with such a method is that it could be
argued that equivalence should be set not at the median UK
graduate but at some lower value, such as, say, the fifth centile
of ability of UK graduates. Considering the right hand part of
figure 2⇓, the fifth centile for UK graduates takingMRCP(UK)
Part 1 was a mark of −16.2, only 5% of UK graduates scoring
less than that. However, of the PLAB graduates, 26.1%, over
five times as many, scored below −16.2. Using the method
described previously, a threshold at PLAB Part 1 could also be
found at which 95% of PLAB graduates score −16.2 or above.
When that is done, the threshold is +27, a value slightly higher
than the +25 we reported in table 5 for the median. The approach
could be extended so that PLAB graduates were required to be
equivalent to the worst performing UK graduate, but any such
analysis of extreme values would be vulnerable to random
sampling variation. Overall, the similarity of estimates based
on the median and the fifth centile suggests that equivalence
calculated on other centiles would have similar results to those
presented here.
Although the median equivalence method we have described
seems to be robust for PLAB Part 1, we note that both PLAB
Part 1 and MRCP(UK) have reliabilities that are above 0.9.30
PLAB Part 2 has a rather lower reliability, at about 0.55 to 0.71,
and that clearly has consequences for the calculation of
equivalence. In an extreme case, were PLAB Part 2 to have a
reliability of zero then no threshold could ever result in
equivalence as all subsamples above any threshold would
necessarily have the same mean. Further consideration and
modelling of the effects of reliability on estimating equivalence
is therefore desirable.
Our second method of evaluating non-equivalence takes known
differences between the graduates of different UK medical
schools as its starting point, some medical schools having
graduates who consistently perform better at postgraduate
medical examinations than do others, with about two thirds of
the variance of those differences probably being due to
differences in qualifications at entry to medical school.24 No
doubt, were it possible to estimate similar findings for the
medical schools attended worldwide by international medical
graduates, then similar differences would probably be found.
International medical graduates taking PLAB are not, though,
either from a random sample of international medical schools
nor are they a random sample of graduates from those medical
schools. International medical graduates wish to practise in the
UK for a host of different reasons.
Our division of PLAB graduates into 12 groups based on Part
1 and Part 2 performance allows comparison with performance
of graduates from UK medical schools. Our equivalence
criterion of not having a mean performance significantly lower
than any UK medical school is a first attempt at using such a
method, and, although there may be an argument that it is
unreasonably conservative, it is also the case that all of the UK
medical schools have been inspected by the GMC and their
graduates found to have acceptable performance standards,
whereas foreign medical schools are not subject to that
inspection. As with our first method, our second method of
evaluating non-equivalence could probably be carried out with
many variations on the basic theme, and that requires future
exploration.
Factors potentially influencing outcome
non-equivalence
Although PLAB graduates and UK graduates do not show
outcome equivalence, interpreting and explaining that difference
is not straightforward, and a number of possible moderating
factors need to be considered. The calculations of our two
methods assess at what level the PLAB pass marks might need
to be set in order to produce outcome equivalence. The
calculations make a number of assumptions, and care must be
taken in interpreting their numerical estimates. The most crucial
assumption, as ever, is “all other things being equal.” However,
all other things cannot be assumed to be equal, although the
extent of the inequality is not known precisely. The numbers in
table 5⇓ should therefore be considered as upper limits of where
the PLAB pass marks may need to be set. Factors that need to
be considered in interpreting the results include the following.
Demographic differences
PLAB graduates inevitably differ demographically from UK
graduates in many ways (see table 2⇓), and some of those ways
may correlate with performance in PLAB and in subsequent
assessments. Although such demographic differences are not
to be disputed, they are mostly not relevant to the primary topic
of this report, which is the assessment of outcome equivalence.
The stated role of PLAB is to allow only doctors who are
equivalent to UK graduates to enter UK medical training and
practise, and if there is equivalence then progression of PLAB
graduates should also be equivalent to that of UK graduates.
The influence of demographic factors may be of sociological
interest for understanding and explaining differences, but the
purpose of postgraduate examinations is to maintain absolute
standards for all doctors, which necessarily will be irrespective
of demography. Unless it is deemed appropriate that professional
standards are to be set at different levels for different
demographic groups, then demographic variables should not be
taken into account in the statistical analyses.
English language proficiency
The PLAB examinations, as well as MRCP(UK) and MRCGP,
are examinations taken in English, and inevitably it is a concern
that doctors with high levels of clinical competence might be
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being excluded because of language problems. However, as
Esmail and Roberts wrote of the CSA, “it is designed to ensure
that doctors are safe to practise in [the] UK,” and PLAB is also
designed with a similar objective, English being the language
in which most consultations and professional interactions take
place in the UK. Language ability, as assessed by IELTS, does
have some influence onMRCP(UK) andMRCGP outcome, but
the effects are small, and overall the conclusion is probably
similar that of the 1986 PLAB review: “The failure of candidates
was due in the main part to their lack of professional knowledge
rather than difficulty in communicating in English.”2
Postgraduate training and experience
All doctors taking the MRCGP have taken part in an approved,
three year deanery training programmewhich takes places after
foundation year 2, with the AKT exam taken after two years
and CSA after three years. In contrast, MRCP(UK) is not
restricted to doctors on training programmes, although many
candidates are in core medical training programmes.
Performance differences in MRCP(UK) and MRCGP may in
part reflect differences in the quality of international medical
graduate and UK medical graduate postgraduate training
programmes. Deaneries undoubtedly differ in the proportion of
international medical graduates on their general practice training
programmes, and there are also differences in success rates.6
Training schemes within deaneries probably also vary in quality,
and it is possible that international medical graduates are
allocated to poorer quality training (and one of us elsewhere
has referred to, “the inverse care law of training … in which
those who most need the added value of education are assigned
to the least popular schemes”37). The quality of postgraduate
education cannot straightforwardly be taken into account without
direct measures of the quality of training programmes and
schemes (and the GMC’s National Training Survey might in
principle provide such measures, particularly if linked to
examination databases). It might also be the case that differences
in postgraduate outcome between UK medical schools are in
part due to differences in training programme quality.38 Clearly
there is an urgent need to take training posts into account.
Direct methods for estimating entry
equivalence
Standard setting is an imperfect science. Our analysis of
outcomes in relation to PLAB attainment levels was motivated
by Kane’s “direct, criterion-related approach” for standard
setting, and it was used because no direct method of assessing
entry equivalence is currently available in the UK. The most
direct method of assessing entry equivalence would be if the
UK had a national qualifying examination that was also taken
by international medical graduates, unchanged and with the
same pass mark as that for UK graduates.
The standard for PLAB is currently set by the Angoff method
for PLAB Part 1, and by a borderline group method for Part 2.
Both methods are well recognised in the literature,39 40 but
Angoff in particular has potential problems.27 41-43 A standard
setting method can be valid, but that does not ensure that an
implementation of the method is valid or appropriate. Using
Kane’s terminology,26 there may be acceptable procedural
validity and internal validity, but they cannot guarantee that a
pass mark is set at the right level.27 Ultimately the validity of a
pass standard is an empirical matter to be assessed by its
relationship to standards set by other methods for other parallel
assessments.
Of its very nature, PLAB is an assessment similar to those
carried out in medical schools throughout the UK. Just as
examining boards at secondary school level work closely
together to ensure that standards on assessments such as A levels
are comparable, using a mixture of statistical and evaluative
methods,23 so PLAB and other equivalent qualifications such
as medical school finals could collaborate on shared standard
setting. A range of direct methods for equating standards is
available, some of which rely on item overlap of assessments22
and of examiners. The inclusion of items from PLAB inmedical
school finals and vice-versa would help in the equating process.
Without any direct method of assessing entry equivalence, the
only conclusion can be that there are no strong reasons to believe
that PLAB standards are at the same level as foundation year
1, and the lack of outcome equivalence, with its large effect
size, is compatible with the PLAB standard being set too low,
although precisely by howmuch is difficult to assess accurately.
The relationship between entry equivalence
and outcome equivalence
An implicit assumption in assessments of entry equivalence is
that entry equivalence and outcome equivalence are directly
related, the former ensuring the latter. Thus it is sometimes
argued, for instance, that since all general practice trainees are
under the supervision of UK postgraduate deaneries, and all
those trainees have passed the PLAB exams (and hence there
is entry equivalence with UK graduates), then PLAB graduates
and UK graduates should also show outcome equivalence when
takingMRCGP. Even were it the case that the standard of PLAB
and foundation year 1 showed exact entry equivalence, that still
would not ensure that, say, international medical graduates and
UK medical graduates would show outcome equivalence. As a
concrete example, international medical graduates applying to
and selected by one deanery, who had entry equivalence to UK
medical graduates, having passed the same selection tests with
the identical pass mark, had lower mean levels of attainment
on the selection tests37, so that outcome equivalence could not
be expected. Entry equivalence can only ensure outcome
equivalence in different groups if the distribution of marks in
those groups is the same, and when distributions are not the
same then outcome equivalence will not occur despite entry
equivalence.
Strengths and weaknesses of this study
The strength of the present study is that it looks at the marks of
a large number of international medical graduates who have
taken PLAB and compares the marks of both international
medical graduates and UK medical graduates on two major
postgraduate assessments, which together are taken by over half
of the UK medical workforce. The data linkage allows
generalisable insights into PLAB that were hitherto unavailable,
and in particular it suggests that the pass mark may not be
appropriate, although the validity of PLAB is affirmed. A
potential weakness of the present study is that it includes data
from only two Royal College examinations, but the separate
analysis of Annual Review of Competence Progression data,
which includes doctors from all specialties and includes
non-examination outcomes, supports the present findings.25 A
weakness of the present study is that it has no information about
the training programmes and schemes on which UK medical
graduates and international medical graduates have been based,
and if international medical graduates systematically have lower
quality training, then that may account for some of the effects
reported here.
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A narrative interpretation
The present study has raised many issues concerning
international medical graduates and their selection and training.
The following paragraph provides a synoptic overview and an
interpretation of the various issues.
International medical graduates undoubtedly perform less well
at MRCP(UK), MRCGP, and Annual Review of Competence
Progression, and probably at other postgraduate examinations.
That seems unlikely to result from systematic examiner bias or
discrimination, not least as the effect size is large, being over
one standard deviation. Some of the difference may well be due
to differences in training programmes, with international medical
graduates systematically being allocated to less good training
programmes due to inequitable access. However, training
programmes would have to be extremely disparate in their
effects to produce an effect size of over one standard deviation.
Other factors, such as language ability, may correlate with
outcome, but probably also correlate to a large extent with prior
medical knowledge, and anyway should in large part have been
taken into account by PLAB and are legitimate reasons for
examination failure. The PLAB pass mark is intended to be set
at the same level as foundation year 1, but there are no formal
mechanisms to ensure that beyond the judgments of a standard
setter. Standard setter judgments have no formal mechanism
for aligning or comparing them with assessments such as
medical school finals, such as item sharing or examiner sharing.
It is therefore plausible that the PLAB pass mark is set too low,
there being little evidence to justify its current level. Even if
there were strict entry equivalence of PLAB and foundation
year 1, the distributions of those taking the assessments are
almost certainly different, with only a small proportion of
medical students failing finals compared with a much higher
proportion of international medical graduates taking PLAB Part
1 and 2. Without similar distributions, and even with entry
equivalence, and even if training and all other factors were the
same, international medical graduates would still be expected
to perform less well at outcome.
Conclusions
PLAB and its predecessor, TRAB, throughout their 40 year
history, have meant to be set at a standard equivalent to that of
UK graduates, currently as at the end of foundation year 1.
Although some early attempts were made at assessing
equivalence by administering the test to UK medical students
and doctors,2 there have been no serious recent attempts at
empirical assessment. Large scale record linkage has now
allowed the sorts of comparison that are described here, and
those data suggest that the standard for PLAB has in recent
years been set too low if equivalent progression by PLAB
graduates to UK graduates is expected and required. The
standard for PLAB therefore needs reconsideration.
We cannot finish without acknowledging the various
implications of these findings. The only concern of the
Professional and Linguistic Assessments Board is with ensuring
that the level of competence of international medical graduates
is sufficient to ensure patient safety. PLAB graduates, though,
currently form a sizeable proportion of the doctors entering the
NHS, and any change in their numbers would inevitably have
consequences for service delivery. Those implications cannot
be a part of this study, but we acknowledge that they are
potentially problematic. Nevertheless, getting the standard of
PLAB at a correct level is fundamental to ensuring the quality
of postgraduate medical education and training, the delivery of
medical care of the highest quality, and thus ensuring patient
safety in the NHS.
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Tables
Table 1| Comparison of performance of PLAB graduates known to have taken MRCP(UK) or MRCGP, or both, with PLAB graduates not
known to have taken either examination within the time windows*
No of graduatesMean (SD) score on first attempt at PLAB relative to
pass mark
PLAB Part 1
15 3239.19 (18.16)Neither MRCP(UK) or MRCGP taken
17617.01 (18.57)MRCGP taken
653310.87 (17.43)MRCP(UK) taken
12347.53 (17.42)MRCP(UK) and MRCGP taken
24 8519.39 (18.00)All PLAB graduates
PLAB Part 2
15 3236.33 (4.57)Neither MRCP(UK) or MRCGP taken
17617.25 (4.35)MRCGP taken
65336.13 (4.56)MRCP(UK) taken
12346.49 (4.48)MRCP(UK) and MRCGP taken
24 8516.35 (4.56)All PLAB graduates
*As the sampling periods for the PLAB and college exams differed, the distribution of the dates the PLAB exams were passed was examined against whether the
college exams were attempted. The table excludes cases with a PLAB Part 1 test date after 13 July 2006 (n=6171) and PLAB Part 2 test date after 12 June 2007
(n=6172) as the distributions suggest that some of the doctors may not have had a chance to take the GP exams having only recently been able to register and
so gain a place on a GP training programme, which is a prerequisite for taking the exams.
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Table 2| Demographics of candidates taking MRCP(UK) and MRCGP exams
Significance
PLAB graduatesUK graduates
Variable No of graduatesValueNo of graduatesValue
NS979824.9 (2.0)24 64024.9 (2.2)Mean (SD) age at qualification (years)
MRCP(UK) candidates
Mean (SD) age at 1st attempt of exam (years):
-981228.7 (4.3)—N/APLAB Part 1
-934429.4 (4.4)—N/APLAB Part 2
P<0.001782330.3 (4.5)18 53226.9 (2.4)MRCP(UK) Part 1
P<0.001513331.5 (4.2)14 09427.7 (2.3)MRCP(UK) Part 2
P<0.001438832.6 (4.1)14 40928.4 (2.3)MRCP(UK) PACES
Mean (SD) interval between 1st attempts of exams (weeks):
P<0.0013947101.3 (75.0)12 09150.0 (32.2)MRCP(UK) Part 1 and Part 2
P<0.001413866.7 (49.7)12 05139.4 (23.5)MRCP(UK) Part 2 and PACES
P<0.001980232.024 63456.3% female
P<0.001980496.324 64141.1% non-white ethnicity*
—95897.8—N/A% UK nationals
MRCGP candidates
Mean (SD) age at 1st attempt of exam (years):
-306728.3 (4.4)—N/APLAB Part 1
-306729.1 (4.5)—N/APLAB Part 2
P<0.001306734.4 (4.6)10 04430.5 (4.7)AKT
P<0.001147836.1 (4.5)448130.9 (4.2)CSA
% non-white ethnicity*:
P<0.001316094.212 15232.3AKT database
P<0.001138194.4592433.1CSA database
% female:
P<0.001306744.8%10 04861.3%AKT database
p<0.001147843.7%448162.5%CSA database
—323312.0%N/AN/A% UK nationals
*Self reported ethnicity from college databases, hence variation in numbers.
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Table 3| Correlations of performance in PLAB Parts 1 and 2 with performance at MRCP(UK) andMRCGP and correlations betweenMRCP(UK)
andMRCGP components. All assessments are at the first attempt, and all correlations are P<0.001. Examinations are divided into knowledge
assessments and clinical assessments
MRCGP CSA (clinical)MRCGP AKT (knowledge)PLAB Part 2 (clinical)PLAB Part 1 (knowledge)
MRCP(UK)
r=0.348* (n=1988)r=0.673* (n=1988)r=0.194 (n=7671)r=0.521 (n=7823)Part 1 (knowledge)
r=0.386* (n=1131)r=0.600* (n=1131)r=0.227 (n=4916)r=0.390 (n=5133)Part 2 (knowledge)
r=0.496* (n=943)r=0.471* (n=943)r=0.274 (n=4120)r=0.171 (n=4386)PACES (clinical)
MRCGP
N/AN/Ar=0.186 (n=3067)r=0.490 (n=3160)AKT (knowledge)
N/AN/Ar=0.321 (n=1388)r=0.232 (n=1411)CSA (clinical)
N/A=Not applicable.
*These data were not collected within the present study but are from a separate collaborative research project between MRCP(UK) and MRCGP.
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Table 4| Mean (SD) marks of UK and PLAB graduates at their first attempt at the various parts of MRCP(UK) and MRCGP exams. (All
differences are significant with P<0.001)
Effect size
PLAB graduatesUK graduates
Exam (first attempt) No of graduatesMean (SD) marksNo of graduatesMean (SD) marks
MRCP(UK)
Δ= −0.947823−8.73 (10.75)18 3520.73 (10.12)Part 1
Δ= −0.915133−0.41 (6.91)14 0946.41 (7.49)Part 2
Δ= −1.404386−6.34 (6.32)14 3761.15 (5.34)PACES*
MRCGP
Δ= −1.0131603.78 (16.23)12 15219.02 (15.04)AKT
Δ= −1.821388−4.61 (10.66)597713.44 (9.93)CSA
*PACES marks were converted to the “old PACES” scoring system
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Table 5| Summary of estimated change in the pass mark of PLAB Part 1 and PLAB Part 2 to produce equivalence, using the two separate
methods described in the text
PLAB Part 2PLAB Part 1
MRCGP CSAMRCP(UK) PACESMRCGP AKTMRCP(UK) Part 2MRCP(UK) Part 1
+10> +18+35+32+25Method 1: Equivalence of
medians
+16 to +18 (+17)+16 to +18 (+17)+15 to +19 (+17)+30 to +34 (+32)+20 to +24 (+22)Method 2: Comparison with
UK medical schools
(midpoint value)
Values are indicated as marks relative to the current pass mark and are in raw marks on the scales of the examinations themselves. The marking scales for PLAB
Part 1 and PLAB Part 2 are not comparable.
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Figures
Fig 1 Summary of the selection, assessment and training of UK doctors (undergraduate and postgraduate) and international
medical graduates (postgraduate only)
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Fig 2Example of derivation of an equivalent median score for PLAB and UK graduates for MRCP(UK) Part 1. (For explanation,
see text)
Fig 3Mean performance on the MRCP(UK) Part 1 of graduates of UK universities (blue points) in relation to the performance
of PLAB graduates divided into 12 groups according to PLAB Part 1 mark at first attempt (red points). EEA graduates are
shown as a green point. MRCP(UK) data does not identify individual schools within the University of London
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Fig 4Mean performance on the MRCP(UK) Part 2 of graduates of UK universities (blue points) in relation to the performance
of PLAB graduates divided into 12 groups according to PLAB Part 1 mark at first attempt (red points). EEA graduates are
shown as a green point. MRCP(UK) data does not identify individual schools within the University of London.
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Fig 5Mean performance on theMRCP(UK) PACES of graduates of UK universities (blue points) in relation to the performance
of PLAB graduates divided into 12 groups according to PLAB Part 2 mark at first attempt (red points). EEA graduates are
shown as a green point. MRCP(UK) data does not identify individual schools within the University of London.
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Fig 6Mean performance on the MRCGP AKT of graduates of UKmedical schools (blue points) in relation to the performance
of PLAB graduates divided into 12 groups according to PLAB Part 1 mark at first attempt (red points). EEA graduates are
shown as a green point.
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Fig 7Mean performance on the MRCGPCSA of graduates of UKmedical schools (blue points) in relation to the performance
of PLAB graduates divided into 12 groups according to PLAB Part 2 mark at first attempt (red points). EEA graduates are
shown as a green point.
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Fig 8 IELTS and MRCGP AKT performance of PLAB graduates. Performance at the AKT (horizontal axis) in relation to
performance at PLAB Part 1 (first attempt) by IELTS score (red ≤7.0, orange 7.5, green ≥8.0)
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Fig 9 IELTS and MRCGP CSA performance of PLAB graduates. Performance at the CSA (horizontal axis) in relation to
performance at PLAB Part 2 (first attempt) by IELTS score (red ≤7.0, orange 7.5, green ≥8.0)
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